OMOP stands for Observational Medical Outcomes Partnership. It was a public-private partnership involving the FDA multiple pharmaceutical companies, and healthcare providers established to inform the appropriate use of observational healthcare databases for studying the effects (risks and benefits) of medical products. OMOP was successfully transitioned to the Reagan-Udall Foundation in 2013.